JCO Precision Oncology : Impact Factor & More
eISSN: 2473-4284pISSN: 2473-4284
Share this on:
Key Metrics
CiteScore 
6.6
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.98
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on JCO Precision Oncology
JCO Precision Oncology Journal Specifications
Indexed in the following public directories
Web of Science 
SJR
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Continuous publication |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2017 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in JCO Precision Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in JCO Precision Oncology
Real-World Patient Characteristics, Mutational Landscape, and Outcomes in Advanced/Metastatic HER2-Mutant Non\u2013Small Cell Lung Cancer
- 18 Jun 2026
- JCO Precision Oncology
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele
- 8 Jun 2026
- JCO Precision Oncology
ErbB Receptor Feedback Inhibitor 1 Mutation in Biliary Tract Cancers: Turning Resistance Into Response
- 3 Jun 2026
- JCO Precision Oncology
Germline Whole-Genome Sequencing in Early-Onset Pediatric Solid Tumors Implicates Novel Risk Factors
- 3 Jun 2026
- JCO Precision Oncology
Selpercatinib as First-Line Therapy in a 9-Month-Old Infant With Metastatic RET Fusion\u2013Positive Sarcoma: A Case Report
- 3 Jun 2026
- JCO Precision Oncology
Clinicogenomic Landscape of Histologic Subtypes in Ovarian Cancer: Real-World Evidence From a Japanese Nationwide Cohort.
- 1 Jun 2026
- JCO precision oncology
Real-World Patient Characteristics, Mutational Landscape, and Outcomes in Advanced/Metastatic HER2-Mutant Non\u2013Small Cell Lung Cancer
- 18 Jun 2026
- JCO Precision Oncology
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele
- 8 Jun 2026
- JCO Precision Oncology
ErbB Receptor Feedback Inhibitor 1 Mutation in Biliary Tract Cancers: Turning Resistance Into Response
- 3 Jun 2026
- JCO Precision Oncology
Germline Whole-Genome Sequencing in Early-Onset Pediatric Solid Tumors Implicates Novel Risk Factors
- 3 Jun 2026
- JCO Precision Oncology
Selpercatinib as First-Line Therapy in a 9-Month-Old Infant With Metastatic RET Fusion\u2013Positive Sarcoma: A Case Report
- 3 Jun 2026
- JCO Precision Oncology
Clinicogenomic Landscape of Histologic Subtypes in Ovarian Cancer: Real-World Evidence From a Japanese Nationwide Cohort.
- 1 Jun 2026
- JCO precision oncology
FAQs on JCO Precision Oncology
How long has JCO Precision Oncology been actively publishing? 
What is the publishing frequency of JCO Precision Oncology?
How many articles did JCO Precision Oncology publish last year?
What is the eISSN & pISSN for JCO Precision Oncology?
What is Citescore for JCO Precision Oncology?
What is SNIP score for JCO Precision Oncology?
What is the SJR for JCO Precision Oncology?
Who is the publisher of JCO Precision Oncology?
